VANGUARD HEALTH CARE INV VGHCX
COM · Open-End Fund · CUSIP 921908307
2
institutional holders
-1 vs Q4 2025
1.8k
shares reported held*
$342.3kreported value*
1 new
0 added
1 reduced
2 sold out
net sold ≈ $159.4k (-837 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $190.50.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 4 |
| Q1 2020 | 2 |
| Q2 2020 | 2 |
| Q3 2020 | 1 |
| Q4 2020 | 1 |
| Q1 2021 | 1 |
| Q2 2021 | 2 |
| Q3 2021 | 3 |
| Q4 2021 | 2 |
| Q1 2022 | 3 |
| Q2 2022 | 2 |
| Q3 2022 | 1 |
| Q4 2022 | 2 |
| Q1 2023 | 3 |
| Q2 2023 | 4 |
| Q3 2023 | 2 |
| Q4 2023 | 3 |
| Q1 2024 | 2 |
| Q2 2024 | 3 |
| Q3 2024 | 3 |
| Q4 2024 | 3 |
| Q1 2025 | 3 |
| Q2 2025 | 2 |
| Q3 2025 | 2 |
| Q4 2025 | 3 |
| Q1 2026 | 2 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 0 | 0 |
| Q3 2024 | 1 | 1 |
| Q4 2024 | 1 | 2 |
| Q1 2025 | 2 | 1 |
| Q2 2025 | 0 | 2 |
| Q3 2025 | 0 | 2 |
| Q4 2025 | 0 | 1 |
| Q1 2026 | 1 | 3 |
Biggest buyers
| McIlrath & Eck, LLC | New | +743 |
Biggest sellers
| Brick & Kyle, Associates | Sold out | -1.5k |
| Garton & Associates Financial Advisors LLC | Sold out | -55 |
| Fairfield Financial Advisors, LTD | Reduced | -43 |
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| Fairfield Financial Advisors, LTD 0.07% of their portfolio | 1.1k $200.8k | Reduced -43 |
| McIlrath & Eck, LLC 0.01% of their portfolio | 743 $141.5k | New |